Top compounds associated with response to SPTLC2


Feature Type Standardized
Nominal ANOVA
mRNA Fumonisin B1 CTRPv2 pan-cancer AAC 0.15 5e-05
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA Sorafenib GDSC1000 pan-cancer AAC 0.2 0.0004
mRNA GDC-0941 FIMM pan-cancer AAC 0.58 0.0005
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0005
mRNA AS605240 GDSC1000 pan-cancer AAC 0.12 0.0006
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.0008
mRNA austocystin d CTRPv2 pan-cancer AAC 0.13 0.0009
mRNA BRD-K48477130 CTRPv2 pan-cancer AAC 0.19 0.001
mRNA ML258 CTRPv2 pan-cancer AAC 0.13 0.001
Download CSV